The pharmaceutical and biotech sectors face immense pressure to innovate, driven by complex disease challenges and the need for personalized medicine. Simultaneously, consumer demand for evidence-based functional ingredients in food and cosmetics is growing rapidly. This technology offers a strategic advantage by accelerating the discovery of novel compounds, enabling companies to meet market demands faster, reduce R&D expenditure, and secure a leading position in highly competitive global industries.
Enables novel functional material discovery by targeting non-natural protein structures, expanding drug discovery potential and opening new markets.
Significantly accelerates functional material discovery speed by 3x through efficient heat-cooling cycle screening, contributing to shorter development timelines.
Offers broad applicability to various protein types, not limited to specific ones, enabling deployment across diverse disease areas and industrial sectors.
The patent successfully overcame a rejection by the examiner, demonstrating its novelty and inventiveness against prior art, indicating high validity. It features 11 claims, broadly covering the method, device, and program for functional material discovery, providing a robust scope for various business models.
This patent primarily covers the method for discovering functional materials. Licensees could develop complementary IP in automated high-throughput screening hardware or advanced AI/ML algorithms for predicting optimal protein destabilization parameters.
This technology could shorten functional material discovery periods by ~20%. For a ~$3.5M/year (AI est.) drug discovery R&D project, this reduction could save ~$0.5M/year (AI est.). Additionally, assuming increased discovery probability adds ~$1M/year (AI est.) in value from commercialized drugs, the total economic impact could reach ~$1.5M/year (AI est.).
X: Novelty & Discovery Potential
Y: Discovery Efficiency & Cost Advantage